Dijokaite-Guraliuc, Aiste http://orcid.org/0000-0002-4850-9709
Das, Raksha
Nutalai, Rungtiwa
Zhou, Daming
Mentzer, Alexander J. http://orcid.org/0000-0002-4502-2209
Liu, Chang
Supasa, Piyada
Dunachie, Susanna J.
Lambe, Teresa
Fry, Elizabeth E.
Mongkolsapaya, Juthathip
Ren, Jingshan http://orcid.org/0000-0003-4015-1404
Huo, Jiandong
Stuart, David I. http://orcid.org/0000-0002-3426-4210
Screaton, Gavin R.
Funding for this research was provided by:
Chinese Academy of Medical Sciences
Chinese Academy of Meteorological Sciences
Core funding from Guangzhou Medical University
Article History
Received: 20 September 2022
Accepted: 7 November 2022
First Online: 29 November 2022
Conflict of interest
: G.R.S. sits on the GSK Vaccines Scientific Advisory Board, is a consultant to Astra Zeneca, and is a founder member of RQ Biotechnology. Oxford University holds intellectual property related to the Oxford-Astra Zeneca vaccine and SARS-CoV-2 mAb discovered in G.R.S’s laboratory. T.L. is named as an inventor on a patent application covering this SARS-CoV-2 vaccine and was a consultant to Vaccitech for an unrelated project whilst the study was conducted. S.J.D. is a Scientific Advisor to the Scottish Parliament on COVID-19.